Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 362.10K | 1.40M | 124.60K | 310.80K | 1.16M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 133.80K | 199.80K | 265.40K | 102.40K | 513.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 495.90K | 1.60M | 390.00K | 413.20K | 1.67M |
|
|
|||||
| Total Current Assets | 495.90K | 1.60M | 390.00K | 413.20K | 1.67M |
| Net Property, Plant & Equipment | 1.70K | 2.00K | 2.30K | 2.50K | 2.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 497.60K | 1.60M | 392.30K | 415.70K | 1.67M |
|
|
|||||
| Total Accounts Payable | 172.60K | 190.40K | 175.60K | 110.60K | 100.90K |
| Total Accrued Expenses | 10.74M | 8.96M | 7.03M | 5.81M | 5.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 93.20K | 161.50K | 252.50K | -- | -- |
| Total Other Current Liabilities | 93.20K | 161.50K | 252.50K | -- | -- |
| Total Current Liabilities | 11.00M | 9.31M | 7.45M | 5.92M | 5.37M |
|
|
|||||
| Total Current Liabilities | 11.00M | 9.31M | 7.45M | 5.92M | 5.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.00M | 9.31M | 7.45M | 5.92M | 5.37M |
|
|
|||||
| Common Stock & APIC | 48.66M | 48.58M | 46.54M | 45.83M | 45.75M |
| Retained Earnings | -58.13M | -55.51M | -53.07M | -51.33M | -49.44M |
| Treasury Stock & Other | 24.30K | -15.10K | -38.90K | -2.70K | -12.00K |
| Total Common Equity | -9.45M | -6.95M | -6.56M | -5.50M | -3.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.45M | -6.95M | -6.56M | -5.50M | -3.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.05M | -762.90K | -497.80K | -- | -- |
| Total Equity | -10.50M | -7.71M | -7.06M | -5.50M | -3.70M |
|
|
|||||